Diabetes Mellitus, Type 1
1,136
79
112
813
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Published Results
224 trials with published results (20%)
Research Maturity
813 completed trials (72% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
5.7%
65 terminated out of 1136 trials
92.6%
+6.0% vs benchmark
17%
189 trials in Phase 3/4
28%
224 of 813 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 813 completed trials
Clinical Trials (1136)
A Study to See the Effect of NNC0194-0499 Alone or in Combination With Semaglutide on Blood Sugar Control in People Living With Type 1 Diabetes
The Role of the Adrenergic System in Hypoglycaemia Induced Inflammatory Response in People With Type 1 Diabetes and People Without Type 1 Diabetes-RAID-II
Therapeutic Strategies for Microvascular Dysfunction in Type 1 Diabetes
Food Insecurity Reduction & Strategy Team
OPT101 in Type 1 Diabetes Patients
A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults
A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
The BRIGHT Study (Device Name: HALO System)
Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes
Phase 2b Trial Comparing HDV-Insulin Lispro to Insulin Lispro in Adults With Type 1 Diabetes Receiving Insulin Degludec
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes
Advanced Hybrid Closed Loop System (AHCL) in Older Patients With Type 1 Diabetes Mellitus
Breaking Disparities in Access to Advanced Diabetes Technologies in Children With Type 1 Diabetes
Hypoglycemia Thresholds in Type 1 Diabetes
Treatment of Presymptomatic (Stage 1) Type 1 Diabetes Pediatric Patients With Treg Cell Preparations and Anti-CD20 Antibody
Peer i-Coaching for Activated Self-Management Optimization in Adolescents and Young Adults With Chronic Conditions
Effect of Inhaled Technosphere Insulin vs RAA Insulin on Exercise-Induced Hypoglycemia in Adults With T1D Using Automated Insulin Delivery
Subcutaneous Pharmacokinetic Evaluation of Monomeric Insulin and Lyumjev in Adults With Type 1 Diabetes
A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes
Family-Based Treatment for Type 1 Diabetes